2007
DOI: 10.1016/j.transproceed.2007.08.031
|View full text |Cite
|
Sign up to set email alerts
|

Adhesion Molecule Polymorphisms in Acute Renal Allograft Rejection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
10
0

Year Published

2009
2009
2019
2019

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(11 citation statements)
references
References 8 publications
1
10
0
Order By: Relevance
“…The prevalence of ICAM1 gene polymorphisms genotype (GG:GA:AA) in our controls was in complete agreement with previously published reports for the Caucasian population (34) and for Tunisian population (35). One other possible explanation for this conflict might be the small sample size in these studies (13, 31, 32).…”
Section: Clinical Characteristics Of Patients With Behçet's Disease Asupporting
confidence: 92%
“…The prevalence of ICAM1 gene polymorphisms genotype (GG:GA:AA) in our controls was in complete agreement with previously published reports for the Caucasian population (34) and for Tunisian population (35). One other possible explanation for this conflict might be the small sample size in these studies (13, 31, 32).…”
Section: Clinical Characteristics Of Patients With Behçet's Disease Asupporting
confidence: 92%
“…Worldwide interest in this group of antigens has been generated in the last few years because several reports concur on its major role in immune complications such as hematopoietic stem cell transplantation (HSCT) outcomes; graft rejection of HLA‐matched solid organ transplants; and foeto‐maternal allo‐immunization (4–12). HA‐1 and HA‐2 are the two human MiHAgs recognized by their restricted expression to hematopoietic and leukemic cells (13, 14).…”
Section: Ha‐1 and Ha‐2 Genotype Frequencies In Tunisiansmentioning
confidence: 99%
“…This study clearly demonstrates that increased immunogenicity after ischemia-reperfusion stress is an integral part of renal HSR. Based on studies of MHC class II and ICAM-1 as key markers of renal immunogenicity (Khazen et al 2007;Mendoza-Carrera et al 2008;Shackleton 1998;Shoskes and Halloran 1991) and Hsp70 as the key marker and HSF-1 as the key regulator of the renal HSR (Shamovsky and Nudler 2008;Pirkkala et al 2001), our data show that HSF-1 plays a role in the concordant upregulation of tubular immunogenicity and HSR, representing a direct molecular link between ischemia-reperfusion injury and renal immunogenicity.…”
Section: Discussionmentioning
confidence: 71%
“…Restitution of blood flow with reperfusion sustains renal allograft injury by further generation of free oxygen radicals. Ischemia-reperfusion and the associated oxidative stress not only disrupt cellular homeostasis but also increase the expression of adhesion molecules such as intercellular adhesion molecule-1 (ICAM-1) and major histocompatibility complex (MHC) classes I and II in interstitial cells and importantly also in renal tubular cells, thereby increasing immunogenicity and risk for allograft rejection (Mendoza-Carrera et al 2008;Khazen et al 2007;Shackleton et al 1990;Shoskes et al 1990;Shackleton 1998). However, the direct molecular link between renal ischemia-reperfusion injury and tubular immunogenicity is still unknown.…”
Section: Introductionmentioning
confidence: 99%